Supplemental and Archived Hepatitis B
as Published in Morbidity and Mortality Weekly Report (MMWR)
Advisory Committee on Immunization Practices (ACIP)
These MMWR publications were published in addition to the official CDC recommendations and serve as updates until the recommendations are revised and republished. These MMWRs contain important changes or supplemental recommendations that may include policy notes, changes or updates to recommendations, and notices to readers.
NOTE: As a general rule, if the official recommendations are dated later than the supplemental recommendations listed below, the official recommendations override the older items listed below.
For your convenience, the "Archived MMWR Publications" section can be used for historical and research purposes.
Supplemental Hepatitis B Recommendations
- October 12, 2007, Vol 56, #40
Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix®)
- Mar 14, 2003, Vol 52, #10
Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX™) for Use in Infants
- Sep 21, 2001, Vol 50, #37
Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
- Mar 31, 2000, Vol 49, #12
Notice to Readers: Alternate Two-Dose Hepatitis B Vaccination Schedule for Adolescents Aged 11-15 Years
- None at this time
Content last reviewed on April 8, 2011
Content Source: National Center for Immunization and Respiratory Diseases